메뉴 건너뛰기
Biochemical Pharmacology
Volumn 75, Issue 6, 2008, Pages
In response to "Selective serotonin reuptake inhibitors-A new modality for the treatment of lymphoma/leukaemia?" by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424-1435]
Author keywords

[No Author keywords available]
Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; RITUXIMAB; SEROTONIN UPTAKE INHIBITOR;
EID: 39749171981     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.02.009     Document Type: Letter
Times cited : (2)
References (6)
  • 1
    • 0037944059 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsylike Burkitt lymphoma cells
    • Serafeim A., Holder M.J., Grafton G., Chamba A., Drayson M.T., Luong Q.T., et al. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsylike Burkitt lymphoma cells. Blood 101 (2003) 3212-3219
    • (2003) Blood , vol.101 , pp. 3212-3219
    • Serafeim, A.1    Holder, M.J.2    Grafton, G.3    Chamba, A.4    Drayson, M.T.5    Luong, Q.T.6
  • 2
    • 21744444436 scopus 로고    scopus 로고
    • The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics
    • Meredith L., Holder M.J., Chamba A., Challa A., Drake Lee A., Bunce C.M., et al. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J 19 (2005) 1187-1189
    • (2005) FASEB J , vol.19 , pp. 1187-1189
    • Meredith, L.1    Holder, M.J.2    Chamba, A.3    Challa, A.4    Drake Lee, A.5    Bunce, C.M.6
  • 3
    • 33845678098 scopus 로고    scopus 로고
    • Is Burkitt's lymphoma sexy enough?
    • Phillips J.A. Is Burkitt's lymphoma sexy enough?. Lancet 368 (2006) 2251-2252
    • (2006) Lancet , vol.368 , pp. 2251-2252
    • Phillips, J.A.1
  • 4
    • 33748622833 scopus 로고    scopus 로고
    • Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: implications for non-Hodgkin's lymphoma
    • Meredith L., Holder M.J., Rosen A., Drake Lee A., Dyer M.J., Barnes N.M., et al. Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: implications for non-Hodgkin's lymphoma. Proc Natl Acad Sci USA 103 (2006) 13485-13490
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 13485-13490
    • Meredith, L.1    Holder, M.J.2    Rosen, A.3    Drake Lee, A.4    Dyer, M.J.5    Barnes, N.M.6
  • 5
    • 39749084775 scopus 로고    scopus 로고
    • Stewart R, Wei W, Challa A, Armitage RJ, Arrand JR, Rowe M, et al. CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cells. J Immunol (in press).
    • Stewart R, Wei W, Challa A, Armitage RJ, Arrand JR, Rowe M, et al. CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cells. J Immunol (in press).
  • 6
    • 27844520930 scopus 로고    scopus 로고
    • Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind Annexin V in response to B cell receptor engagement: a cautionary tale
    • Holder M., Barnes N.M., Gregory C.D., and Gordon J. Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind Annexin V in response to B cell receptor engagement: a cautionary tale. Leukemia Res 30 (2006) 77-80
    • (2006) Leukemia Res , vol.30 , pp. 77-80
    • Holder, M.1    Barnes, N.M.2    Gregory, C.D.3    Gordon, J.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.